NEXIEN BIOPHARMA, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2017-12-08: Federal exemption Rule 506(b); Types of securities offered Equity; SecurityToBeAcquired; Date of first sale 2017-12-05; Total offering amount $1,261,532.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2017-12-08 | Rule 506(b) | Equity; SecurityToBeAcquired | 2017-12-05 | $1,261,532 | $45,200 | $1,216,332 | 2 |